Search

everythinglearnresearchcommunity

for

Search:↓

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Tissue-derived extracellular vesicles are crucial for cancer diagnosis, prognosis, and treatment.

Dermatologists should carefully manage hair loss in cancer patients to improve their quality of life.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Estrogens and SERMs can help with skin aging, but their safety and effectiveness need more research.

Male rats have more somatostatin neurons than females due to testosterone converting to estrogen during early development.

No definitive link between finasteride and male breast cancer, but further research is needed.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Nano-sized plant-based chemicals could improve cervical cancer treatment by being more effective and causing fewer side effects than current methods.

Natural products can help overcome cancer drug resistance.

Electric pulse treatments for breast cancer show promise in being safer and more effective, with fewer side effects.

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

A group has developed therapies that show promise for treating cancer and various other conditions.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

Steroid-producing capabilities in certain cancers may contribute to treatment resistance.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Tamoxifen caused hair loss in a 52-year-old woman.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

TGFβ's manipulation of inflammation and immune cells affects cancer spread, suggesting new treatment strategies and biomarkers.

Scalp cooling helps prevent hair loss during chemotherapy, and minoxidil aids regrowth.

Keratins help protect cells, aid in cancer diagnosis, and influence cancer behavior and treatment.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Runx1 controls fat-related genes important for normal and cancer cell growth, affecting skin and hair cell behavior.